Back to search results

AB122 Platform Study

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced or Metastatic Solid Tumor · Pancreatic Ductal Adenocarcinoma · Colorectal Cancer · Non-small Cell Lung Cancer · Gastric Cancer · Alveolar Soft Part Sarcoma · Esophageal Cancer · Head and Neck Cancer · Biliary Tract Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • A site selected by Taiho Pharmaceutical Co., Ltd., Aichi, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Chiba, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Ehime, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Hokkaido, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Kanagawa, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Osaka, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Shizuoka, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan

  • A site selected by Taiho Pharmaceutical Co., Ltd., Wakayama, Japan

Study leads

  • Taiho Pharmaceutical Co., Ltd.

    Study Director

    Taiho Pharmaceutical Co., Ltd.

View source on ClinicalTrials.gov(opens in a new tab)